CSIMarket
 
Aclaris Therapeutics Inc   (ACRS)
Other Ticker:  
 
 

Aclaris Therapeutics Inc Cash flow Statement Quarterly

ACRS



Select the Financial Report:   Period:   Fiscal Year:



Cash flow Statement
(Quarterly, GAAP in millions $)

(Jun 30 2024)
6 Months
(Mar 31 2024)
3 Months
(Dec 31 2023)
12 Months
(Sep 30 2023)
9 Months
(Jun 30 2023)
6 Months
Income -27.93 -16.94 -88.48 -86.99 -57.73
Depreciation & amortization 0.49 0.24 0.86 0.64 0.42
Amortization of Other Assets - - - - -
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense - - - - -
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability 3.00 2.80 -20.27 -0.60 -2.30
Provision for Loan, Lease, and Other Losses - - - - -
Increase (Decrease) in Inventories - - - - -
R & D, Environmental and Other Expense - - - - -
Gain (Loss) on Disposition of Assets - - - - -
Share-based Compensation 4.99 2.09 20.54 19.28 13.33
Income (Loss) from Equity Method Investments - - - - -
Gains (Losses) on Extinguishment of Debt - - - - -
Gain Of Sale Of Product Under Collaborative Arrangement - - - - -
Income taxes - - -0.37 - -
Losses/ -gains on Investments net - - - - -
Increase (Decrease) in Accounts Receivable -0.03 -0.08 0.19 0.14 0.05
Increase (Decrease) in Accounts Payable -1.61 1.93 -1.47 -1.08 1.07
Increase (Decrease) in Accrued Liabilities -14.37 -12.91 11.99 6.35 -0.24
Deferred Revenue and Customer Advances and Deposits - - - - -
Increase (Decrease) in Prepaid Expense and Other Assets 2.32 2.04 -1.32 -9.29 -1.61
Other Working Capital - - - - -
Other Noncash Items - - - - -
Other net - - - - -
Payments for (Proceeds from) Other Operating Activities - 0.00 0.00 - -
Discontinued operations - - - - -
Net Cash flow from Operating Activities -33.14 -20.82 -78.33 -71.56 -47.01
Capital Expenditures -0.12 -0.14 -1.31 -0.87 -0.78
Sale of Capital Items - - - - -
Proceeds from Sale and Maturity of Marketable Securities 51.50 16.97 183.20 175.21 125.43
Payments to Acquire Marketable Securities -35.22 - -135.68 -135.68 -118.51
Real Estate Investments - - - - -
Payments To Acquire Product Under Collaborative Arrangement - - - - -
Receipts From Disposition Of Product Under Collaborative Arrangement - - - - -
Restricted Cash and Investments Increase (Decrease) - - - - -
Payments for (Proceeds from) Loans - - - - -
Payments for (Proceeds from) Deposits - - - - -
Payments for (Proceeds from) Other Investments - - - - -
Payments for (Proceeds from) Federal Reserve and Federal Home Loan Bank - - - - -
Payments to Acquire Businesses, Net of Cash Acquired - - - - -
Interest in Subsidiaries and Affiliates - - - - -
Sale of businesses - - - - -
Accounts payable - - - - -
Receivables - - - - -
Payments for (Proceeds from) Other Investing Activities - - - - -
Other Net 0.00 - - 0.00 0.00
Discontinued operations - - - - -
Net Cash flow from Investing Activities 16.16 16.83 46.22 38.67 6.14
Short-term debt Net - - - - -
Other borrowing transactions - - - - -
Long-term debt - borrowings - - - - -
Long-term debt - repayments - - - - -
Federal Home Loan Bank and Federal Funds - - - - -
Issuances/ -repurchases of Comm. Stock - - 0.09 0.05 0.03
Partnership and Parent Transactions - - - - -
Issuances/ -repurchases of Pref. Stock - - - - -
Deposits, Annuities, Contract Holders Funds - - - - -
Other financing activities net - - - - -
Other net -0.07 -0.06 -0.10 -0.48 -0.39
Proceeds From Issuance Of Convertible Preferred Stock Net Of Issuance Costs - - - - -
Proceeds From Issuance Of Private Placement Net Of Issuance Costs - - - - -
Proceeds From Issuance Of Common Stock Net Of Issuance Costs - - - - -
Proceeds From Issuance Initial Public Offering Net Of Issuance Costs - - - - -
Payment Of Development Milestone Financing - - - - -
Finance Lease Principal Payments - - - - -
Sale Of Stock Consideration Received On Transaction 26.71 26.71 - - -
Capital Expenditures Incurred But Not Yet Paid 0.38 0.39 0.04 0.07 0.11
Fair Value Of Warrants Issued In Connection With Debt Financing - - - - -
Operating Lease Asset Recorded As Result Of New Accounting Standard - - - - -
Stock Issued - - - - -
Payments of Dividends, Preferred Stock and Preference Stock - - - - -
Dividends paid - - - - -
Net Cash flow from Financing Activities -0.07 -0.06 26.71 26.66 26.74
Effect of exchange rate on cash flow - - - - -
Discontinued operations - - - - -
Free Cash Flow -33.26 -20.95 -79.63 -72.43 -47.79
Total Cash Flow -17.04 -4.04 -5.40 -6.24 -14.13




Untitled Document





	
	


Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com